Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Zanamivir vs Oseltamivir in Hospitalized Influenza (Phase 3)
CTR20130098Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zanamivir in influenza, sponsored by GSK. Started Jan 2016; status: completed.
02
Drugs
zanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20130098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130098.